Cytogen Corp said its willexpand clinical trials of its cancer imaging technology. Itsaid the new studies were anticipated to begin by mid year.    It said the first phase of human testing begain in October.The technology uses a monocloncal antibody tagged with aradioisotope to diagnose colorectal cancer and severalother cancer types. It said preliminary studies revealed theantibody combination was well tolerated in the patientsstudied. Reuter&#3;